tiprankstipranks
Trending News
More News >
Nath Bio-Genes (India) Ltd. (IN:NATHBIOGEN)
:NATHBIOGEN
India Market

Nath Bio-Genes (India) Ltd. (NATHBIOGEN) Financial Statements

Compare
2 Followers

Nath Bio-Genes (India) Ltd. Financial Overview

Nath Bio-Genes (India) Ltd.'s market cap is currently ₹3.77B. The company's EPS TTM is ₹20.672; its P/E ratio is 9.86; and it has a dividend yield of 1.01%. Nath Bio-Genes (India) Ltd. is scheduled to report earnings on January 23, 2025, and the estimated EPS forecast is ₹―. See an overview of income statement, balance sheet, and cash flow financials.
Mar 25Mar 24Mar 23Mar 22Mar 21
Income Statement
Total Revenue₹ 3.65B₹ 2.48B₹ 3.01B₹ 2.78B₹ 3.07B
Gross Profit₹ 2.29B₹ 1.03B₹ 1.67B₹ 1.54B₹ 1.71B
Operating Income₹ 459.82M₹ 477.02M₹ 457.34M₹ 345.70M₹ 643.36M
EBITDA₹ 497.98M₹ 536.39M₹ 488.91M₹ -497.06M₹ 684.33M
Net Income₹ 386.00M₹ 396.19M₹ 350.11M₹ -673.38M₹ 556.62M
Balance Sheet
Cash & Short-Term Investments₹ 888.99M₹ 774.10M₹ 2.09B₹ 41.68M₹ 292.11M
Total Assets₹ 10.26B₹ 8.80B₹ 7.93B₹ 7.42B₹ 7.90B
Total Debt₹ 1.23B₹ 1.10B₹ 1.05B₹ 929.59M₹ 965.67M
Net Debt₹ 336.01M₹ 329.41M₹ 672.17M₹ 887.91M₹ 673.55M
Total Liabilities₹ 3.82B₹ 2.70B₹ 2.20B₹ 2.00B₹ 1.76B
Stockholders' Equity₹ 6.44B₹ 6.10B₹ 5.73B₹ 5.42B₹ 6.13B
Cash Flow
Free Cash Flow₹ 96.61M₹ 478.18M₹ 358.18M₹ -39.70M₹ -104.86M
Operating Cash Flow₹ 175.81M₹ 745.94M₹ 383.67M₹ 170.46M₹ 11.13M
Investing Cash Flow₹ -39.62M₹ -274.01M₹ -28.84M₹ -198.66M₹ -102.82M
Financing Cash Flow₹ -21.30M₹ -77.78M₹ -16.68M₹ -222.27M₹ 164.01M
Currency in INR

Nath Bio-Genes (India) Ltd. Earnings and Revenue History

Nath Bio-Genes (India) Ltd. Debt to Assets

Nath Bio-Genes (India) Ltd. Cash Flow

Nath Bio-Genes (India) Ltd. Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis